نتائج البحث - "Pechonkina, Alena"

1

دورية أكاديمية

Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study

المؤلفون: Combe, Bernard G., Tanaka, Yoshiya, Buch, Maya H., Nash, Peter, Burmester, Gerd R., Kivitz, Alan J., Bartok, Beatrix, Pechonkina, Alena, Xia, Katrina, Emoto, Kahaku, Kano, Shungo, Hendrikx, Thijs K., Landewé, Robert B. M., Aletaha, Daniel

المصدر: Rheumatology and Therapy ; ISSN 2198-6576 2198-6584

مصطلحات موضوعية: Immunology and Allergy, Rheumatology

الإتاحة: https://doi.org/10.1007/s40744-022-00530-0Test

View record in BASE

2

دورية أكاديمية

Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study

المؤلفون: Combe, Bernard G, Tanaka, Yoshiya, Buch, Maya H, Nash, Peter, Burmester, Gerd R, Kivitz, Alan J, Bartok, Beatrix, Pechonkina, Alena, Xia, Katrina, Emoto, Kahaku, Kano, Shungo, Hendrikx, Thijs K, Landewe, Robert BM, Aletaha, Daniel

مصطلحات موضوعية: Immunology, Pharmacology and pharmaceutical sciences, Science & Technology, Life Sciences & Biomedicine, Rheumatology, Filgotinib, Poor prognostic factors

العلاقة: Rheumatology and Therapy; Combe, BG; Tanaka, Y; Buch, MH; Nash, P; Burmester, GR; Kivitz, AJ; Bartok, B; Pechonkina, A; Xia, K; Emoto, K; Kano, S; Hendrikx, TK; Landewe, RBM; Aletaha, D, Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study, Rheumatology and Therapy, 2022; http://hdl.handle.net/10072/419057Test

الإتاحة: https://doi.org/10.1007/s40744-022-00498-xTest
http://hdl.handle.net/10072/419057Test

View record in BASE

النص الكامل

3

دورية أكاديمية

Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials

المؤلفون: Tanaka, Yoshiya, Atsumi, Tatsuya, Aletaha, Daniel, Bartok, Beatrix, Pechonkina, Alena, Han, Ling, Emoto, Kahaku, Kano, Shungo, Rajendran, Vijay, Takeuchi, Tsutomu

المساهمون: Gilead Sciences, Eisai

المصدر: Rheumatology and Therapy ; ISSN 2198-6576 2198-6584

مصطلحات موضوعية: Immunology and Allergy, Rheumatology

الإتاحة: https://doi.org/10.1007/s40744-022-00503-3Test

View record in BASE

4

دورية أكاديمية

Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren’s syndrome: a randomized, phase 2, double-blind, placebo-controlled study

المؤلفون: Price, Elizabeth, Bombardieri, Michele, Kivitz, Alan, Matzkies, Franziska, Gurtovaya, Oksana, Pechonkina, Alena, Jiang, Wendy, Downie, Bryan, Mathur, Anubhav, Mozaffarian, Afsaneh, Mozaffarian, Neelufar, Gottenberg, J Eric

المساهمون: Gilead Sciences, Inc

المصدر: Rheumatology ; volume 61, issue 12, page 4797-4808 ; ISSN 1462-0324 1462-0332

الإتاحة: https://doi.org/10.1093/rheumatology/keac167Test
https://academic.oup.com/rheumatology/article-pdf/61/12/4797/47385986/keac167.pdfTest

View record in BASE

5

دورية أكاديمية

Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3)

المؤلفون: Atsumi, Tatsuya, Tanaka, Yoshiya, Matsubara, Tsukasa, Amano, Koichi, Ishiguro, Naoki, Sugiyama, Eiji, Yamaoka, Kunihiro, Westhovens, René, Ching, Daniel W T, Messina, Osvaldo Daniel, Burmester, Gerd R, Genovese, Mark, Bartok, Beatrix, Pechonkina, Alena, Kondo, Akira, Yin, Zhaoyu, Gong, Qi, Tasset, Chantal, Takeuchi, Tsutomu

المساهمون: Gilead Sciences, Inc., Foster City, CA

المصدر: Modern Rheumatology ; volume 33, issue 4, page 657-667 ; ISSN 1439-7595 1439-7609

الإتاحة: https://doi.org/10.1093/mr/roac083Test
https://academic.oup.com/mr/article-pdf/33/4/657/50797262/roac083.pdfTest

View record in BASE

6

دورية أكاديمية

Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results

المصدر: Modern Rheumatology ; volume 33, issue 4, page 668-679 ; ISSN 1439-7595 1439-7609

مصطلحات موضوعية: Rheumatology

الإتاحة: https://doi.org/10.1093/mr/roac084Test
https://academic.oup.com/mr/article-pdf/33/4/668/50797274/roac084.pdfTest

View record in BASE

7

دورية أكاديمية

Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years

المساهمون: Gilead Sciences, Inc. Gilead Sciences K.K. and Galapagos NV

المصدر: Modern Rheumatology ; volume 33, issue 1, page 64-72 ; ISSN 1439-7595 1439-7609

مصطلحات موضوعية: Rheumatology

الإتاحة: https://doi.org/10.1093/mr/roac020Test
https://academic.oup.com/mr/article-pdf/33/1/64/48626575/roac020.pdfTest

View record in BASE

8

دورية أكاديمية

Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).

المؤلفون: Tanaka, Yoshiya, Matsubara, Tsukasa, Atsumi, Tatsuya, Amano, Koichi, Ishiguro, Naoki, Sugiyama, Eiji, Yamaoka, Kunihiro, Combe, Bernard G, Kivitz, Alan J, Bae, Sang-Cheol, Keystone, Edward C, Nash, Peter, Matzkies, Franziska, Bartok, Beatrix, Pechonkina, Alena

مصطلحات موضوعية: Clinical sciences, Immunology, Filgotinib, Janus kinase, Japanese, Phase 3 clinical trials, rheumatoid arthritis

العلاقة: Modern Rheumatology; Tanaka, Y; Matsubara, T; Atsumi, T; Amano, K; Ishiguro, N; Sugiyama, E; Yamaoka, K; Combe, BG; Kivitz, AJ; Bae, S-C; Keystone, EC; Nash, P; Matzkies, F; Bartok, B; Pechonkina, A; Kondo, A; Ye, L; Guo, Y; Tasset, C; Sundy, JS; Takeuchi, T, Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1)., Modern Rheumatology, 2021; http://hdl.handle.net/10072/411434Test

الإتاحة: https://doi.org/10.1093/mr/roab030Test
http://hdl.handle.net/10072/411434Test

View record in BASE